Scholl C - Search Results

1

Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia.

Horak P, Uhrig S, Witzel M, Gil-Farina I, Hutter B, Rath T, Gieldon L, Balasubramanian GP, Pastor X, Heilig CE, Richter D, Schröck E, Ball CR, Brors B, Braun CJ, Albert MH, Scholl C, von Kalle C, Schmidt M, Fröhling S, Klein C, Glimm H. Horak P, et al. Among authors: scholl c. Leukemia. 2020 Oct;34(10):2785-2789. doi: 10.1038/s41375-020-0779-z. Epub 2020 Mar 3. Leukemia. 2020. PMID: 32127638 Free PMC article. No abstract available.

2

Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia.

Fischer K, Scholl C, Sàlat J, Fröhling S, Schlenk R, Bentz M, Stilgenbauer S, Lichter P, Döhner H. Fischer K, et al. Among authors: scholl c. Blood. 1996 Nov 15;88(10):3962-71. Blood. 1996. PMID: 8916963 Free article.

3

Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.

Scholl C, Breitinger H, Schlenk RF, Döhner H, Fröhling S, Döhner K; AML Study Group Ulm. Scholl C, et al. Genes Chromosomes Cancer. 2003 Nov;38(3):274-80. doi: 10.1002/gcc.10284. Genes Chromosomes Cancer. 2003. PMID: 14506704

4

Genetics of myeloid malignancies: pathogenetic and clinical implications.

Fröhling S, Scholl C, Gilliland DG, Levine RL. Fröhling S, et al. Among authors: scholl c. J Clin Oncol. 2005 Sep 10;23(26):6285-95. doi: 10.1200/JCO.2005.05.010. J Clin Oncol. 2005. PMID: 16155011 Review.

5

The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.

Scholl C, Schlenk RF, Eiwen K, Döhner H, Fröhling S, Döhner K; AML Study Group. Scholl C, et al. Haematologica. 2005 Dec;90(12):1626-34. Haematologica. 2005. PMID: 16330435

6

HOX gene regulation in acute myeloid leukemia: CDX marks the spot?

Fröhling S, Scholl C, Bansal D, Huntly BJ. Fröhling S, et al. Among authors: scholl c. Cell Cycle. 2007 Sep 15;6(18):2241-5. doi: 10.4161/cc.6.18.4656. Epub 2007 Jun 29. Cell Cycle. 2007. PMID: 17881901 Review.

7

An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML.

Bullinger L, Döhner K, Kranz R, Stirner C, Fröhling S, Scholl C, Kim YH, Schlenk RF, Tibshirani R, Döhner H, Pollack JR. Bullinger L, et al. Among authors: scholl c. Blood. 2008 May 1;111(9):4490-5. doi: 10.1182/blood-2007-09-115055. Epub 2008 Feb 28. Blood. 2008. PMID: 18309032 Free article.

8

Deregulation of signaling pathways in acute myeloid leukemia.

Scholl C, Gilliland DG, Fröhling S. Scholl C, et al. Semin Oncol. 2008 Aug;35(4):336-45. doi: 10.1053/j.seminoncol.2008.04.004. Semin Oncol. 2008. PMID: 18692684 Review.

9

Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia.

Corbacioglu A, Scholl C, Schlenk RF, Eiwen K, Du J, Bullinger L, Fröhling S, Reimer P, Rummel M, Derigs HG, Nachbaur D, Krauter J, Ganser A, Döhner H, Döhner K. Corbacioglu A, et al. Among authors: scholl c. J Clin Oncol. 2010 Aug 10;28(23):3724-9. doi: 10.1200/JCO.2010.28.6468. Epub 2010 Jul 12. J Clin Oncol. 2010. PMID: 20625124 Clinical Trial.

10

STK33 kinase is not essential in KRAS-dependent cells--letter.

Fröhling S, Scholl C. Fröhling S, et al. Among authors: scholl c. Cancer Res. 2011 Dec 15;71(24):7716; author reply 7717. doi: 10.1158/0008-5472.CAN-11-2495. Epub 2011 Nov 29. Cancer Res. 2011. PMID: 22127923 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters